Bone Marrow-Derived Mesenchymal Stem Cells Favor the Immunosuppressive T Cells Skewing in a Helicobacter Pylori Model of Gastric Cancer

Stem Cells and Development

Volumn 22, Issue 21, 2013, Pages 2836-2848

  Lin, Rong ^a   Ma, Huan ^a   Ding, Zhen ^a   Shi, Weina ^a   Qian, Wei ^a   Song, Jun ^a   Hou, Xiaohua ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR ALPHA; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR GATA 3; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CD4 LYMPHOCYTE PERCENTAGE; CD4+ CD25+ T LYMPHOCYTE; CELL MIGRATION; CELL PROLIFERATION; COCULTURE; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; GASTRIN CELL; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HEMATOPOIETIC STEM CELL; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; LYMPHOCYTE FUNCTION; MALE; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; MONONUCLEAR CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SPLEEN CELL; STOMACH; STOMACH CANCER; STOMACH MUCOSA; SUPERNATANT; T LYMPHOCYTE; TH17 CELL; TUMOR MICROENVIRONMENT;

ANIMALS; BONE MARROW CELLS; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; EPITHELIAL CELLS; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; GASTRIC MUCOSA; GATA3 TRANSCRIPTION FACTOR; GENE EXPRESSION; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; INTERFERON-GAMMA; INTERLEUKIN-10; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED BALB C; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STOMACH NEOPLASMS; T-LYMPHOCYTES; T-LYMPHOCYTES, REGULATORY;

EID: 84885773357     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2013.0166     Document Type: Article

References (60)

1. Ferlay J, HR Shin, F Bray, D Forman, C Mathers and DM Parkin. (2010). Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127:2893-2917.
2. Correa P. (1992). Human gastric carcinogenesis: A multistep and multifactorial process-First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res 52:6735-6740.
3. Karin M and FR Greten. (2005). NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol 5:749-759.
4. Grivennikov SI, FR Greten and M Karin. (2010). Immunity, inflammation, and cancer. Cell 140:883-899.
5. Peek RM, C Fiske and KT Wilson. (2010). Role of Innate Immunity in Helicobacter pylori-Induced Gastric Malignancy. Physiol Rev 90:831-858.
6. Wroblewski LE, RM Peek and KT Wilson. (2010). Helicobacter pylori and gastric cancer: factors that modulate disease risk. Clin Microbiol Rev 23:713-739.
7. Straubinger RK, A Greiter, SP McDonough, A Gerold, E Scanziani, S Soldati, D Dailidiene, G Dailide, DE Berg and KW Simpson. (2003). Quantitative evaluation of inflammatory and immune responses in the early stages of chronic Helicobacter pylori infection. Infect Immun 71:2693-2703.
8. Worthley DL, A Ruszkiewicz, R Davies, S Moore, I Nivison- Smith, L Bik To, P Browett, R Western, S Durrant, et al. (2009). Human gastrointestinal neoplasia-associated myofibroblasts can develop from bone marrow-derived cells following allogeneic stem cell transplantation. Stem Cells 27: 1463-1468.
9. Lundin BS, K Enarsson, B Kindlund, A Lundgren, E Johnsson, M Quiding-Jarbrink and AM Svennerholm. (2007). The local and systemic T-cell response to Helicobacter pylori in gastric cancer patients is characterised by production of interleukin-Clin Immunol 125:205-213.
10. Maruyama T, K Kono, Y Mizukami, Y Kawaguchi, K Mimura, M Watanabe, S Izawa and H Fujii. (2010). Distribution of Th17 cells and FoxP3( + ) regulatory T cells in tumorinfiltrating lymphocytes, tumor-draining lymph nodes and peripheral blood lymphocytes in patients with gastric cancer. Cancer Sci 101:1947-1954.
11. Enarsson K, A Lundgren, B Kindlund, M Hermansson, G Roncador, AH Banham, BS Lundin and M Quiding-Jarbrink. (2006). Function and recruitment of mucosal regulatory T cells in human chronic Helicobacter pylori infection and gastric adenocarcinoma. Clin Immunol 121:358-368.
12. Koebel CM, W Vermi, JB Swann, N Zerafa, SJ Rodig, LJ Old, MJ Smyth and RD Schreiber. (2007). Adaptive immunity maintains occult cancer in an equilibrium state. Nature 450: 903-907.
13. Teng MW, PK Darcy and MJ Smyth. (2011). Stable IL-10: A new therapeutic that promotes tumor immunity. Cancer Cell 20:691-693.
14. Varon C, P Dubus, F Mazurier, C Asencio, L Chambonnier, J Ferrand, A Giese, N Senant-Dugot, M Carlotti and F Megraud. (2012). Helicobacter pylori infection recruits bone marrow-derived cells that participate in gastric preneoplasia in mice. Gastroenterology 142:281-291.
15. Houghton J, C Stoicov, S Nomura, AB Rogers, J Carlson, H Li, X Cai, JG Fox, JR Goldenring and TC Wang. (2004). Gastric cancer originating from bone marrow-derived cells. Science 306:1568-1571.
16. Ferrand J, P Lehours, A Schmid-Alliana, F Megraud and C Varon. (2011). Helicobacter pylori infection of gastrointestinal epithelial cells in vitro induces mesenchymal stem cell migration through an NF-kappaB-dependent pathway. PLoS One 6:e29007.
17. Gebler A, O Zabel and B Seliger. (2012). The immunomodulatory capacity of mesenchymal stem cells. Trends Mol Med 18:128-134.
18. Jung KH, SU Song, T Yi, MS Jeon, SW Hong, HM Zheng, HS Lee, MJ Choi, DH Lee and SS Hong. (2011). Human bone marrow-derived clonal mesenchymal stem cells inhibit inflammation and reduce acute pancreatitis in rats. Gastroenterology 140:998-1008.
19. Di Nicola M, C Carlo-Stella, M Magni, M Milanesi, PD Longoni, P Matteucci, S Grisanti and AM Gianni. (2002). Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 99:3838-3843.
20. Krampera M, S Glennie, J Dyson, D Scott, R Laylor, E Simpson and F Dazzi. (2003). Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigenspecific T cells to their cognate peptide. Blood 101:3722-3729.
21. Ohshima M, K Yamahara, S Ishikane, K Harada, H Tsuda, K Otani, A Taguchi, M Miyazato, S Katsuragi, et al. (2012). Systemic transplantation of allogenic fetal membranederived mesenchymal stem cells suppresses Th1 and Th17 T cell responses in experimental autoimmune myocarditis. J Mol Cell Cardiol 53:420-428.
22. English K, A French and KJ Wood. (2010). Mesenchymal stromal cells: facilitators of successful transplantation Cell Stem Cell 7:431-442.
23. Casiraghi F, N Azzollini, P Cassis, B Imberti, M Morigi, D Cugini, RA Cavinato, M Todeschini, S Solini, et al. (2008). Pretransplant infusion of mesenchymal stem cells prolongs the survival of a semiallogeneic heart transplant through the generation of regulatory T cells. J Immunol 181:3933-3946.
24. Parekkadan B, AW Tilles and ML Yarmush. (2008). Bone marrow-derived mesenchymal stem cells ameliorate autoimmune enteropathy independently of regulatory T cells. Stem Cells 26:1913-1919.
25. Karnoub AE, AB Dash, AP Vo, A Sullivan, MW Brooks, GW Bell, AL Richardson, K Polyak, R Tubo and RA Weinberg. (2007). Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 449:557-563.
26. Hutchinson L, B Stenstrom, DA Chen, B Piperdi, S Levey, S Lyle, TC Wang and J Houghton. (2011). Human Barretts adenocarcinoma of the esophagus, associated myofibroblasts, and endothelium can arise from bone marrowderived cells after allogeneic stem cell transplant. Stem Cells Dev 20:11-17.
27. Avital I, AL Moreira, DS Klimstra, M Leversha, EB Papadopoulos, M Brennan and RJ Downey. (2007). Donorderived human bone marrow cells contribute to solid organ cancers developing after bone marrow transplantation. Stem Cells 25:2903-2909.
28. Lee A, J ORourke, MC De Ungria, B Robertson, G Daskalopoulos and MF Dixon. (1997). A standardized mouse model of Helicobacter pylori infection: Introducing the Sydney strain. Gastroenterology 112:1386-1397.
29. Landgraf K, R Brunauer, G Lepperdinger and B Grubeck- Loebenstein. (2011). The suppressive effect of mesenchymal stromal cells on T cell proliferation is conserved in old age. Transplant Immunol 25:167-172.
30. Bernhardt A, D Kuester, A Roessner, T Reinheckel and S Krueger. (2010). Cathepsin X-deficient gastric epithelial cells in co-culture with macrophages: Characterization of cytokine response and migration capability after Helicobacter pylori infection. J Biol Chem 285:33691-33700.
31. Livak KJ and TD Schmittgen. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25:402-408.
32. Lin R, R Murtazina, B Cha, M Chakraborty, R Sarker, TE Chen, Z Lin, BM Hogema, HR de Jonge, et al. (2011). Dglucose acts via sodium/glucose cotransporter 1 to increase NHE3 in mouse jejunal brush border by a Na +/H+ exchange regulatory factor 2-dependent process. Gastroenterology 140:560-571.
33. Long Y, W Wang, H Wang, L Hao, W Qian and X Hou. (2012). Characteristics of intestinal lamina propria dendritic cells in a mouse model of postinfectious irritable bowel syndrome. J Gastroenterol Hepatol 27:935-944.
34. Kao JY, M Zhang, MJ Miller, JC Mills, B Wang, M Liu, KA Eaton, W Zou, BE Berndt, et al. (2010). Helicobacter pylori immune escape is mediated by dendritic cell-induced Treg skewing and Th17 suppression in mice. Gastroenterology 138:1046-1054.
35. Wang L, T Yang, W Qian and X Hou. (2011). The role of endocannabinoids in visceral hyposensitivity induced by rapid eye movement sleep deprivation in rats: Regional differences. Int J Mol Med 27:119-126.
36. Peister A, JA Mellad, BL Larson, BM Hall, LF Gibson and DJ Prockop. (2004). Adult stem cells from bone marrow (MSCs) isolated from different strains of inbred mice vary in surface epitopes, rates of proliferation, and differentiation potential. Blood 103:1662-1668.
37. Anjos-Afonso F, EK Siapati and D Bonnet. (2004). In vivo contribution of murine mesenchymal stem cells into multiple cell-types under minimal damage conditions. J Cell Sci 117:5655-5664.
38. Sfanos KS, TC Bruno, CH Maris, L Xu, CJ Thoburn, AM DeMarzo, AK Meeker, WB Isaacs and CG Drake. (2008). Phenotypic analysis of prostate-infiltrating lymphocytes reveals TH17 and Treg skewing. Clin Cancer Res 14:3254-3261.
39. Zou W. (2006). Regulatory T cells, tumour immunity and immunotherapy. Nat Rev Immunol 6:295-307.
40. Kryczek I, S Wei, L Zou, S Altuwaijri, W Szeliga, J Kolls, A Chang and W Zou. (2007). Cutting edge: Th17 and regulatory T cell dynamics and the regulation by IL-2 in the tumor microenvironment. J Immunol 178:6730-6733.
41. Kryczek I, M Banerjee, P Cheng, L Vatan, W Szeliga, S Wei, E Huang, E Finlayson, D Simeone, et al. (2009). Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments. Blood 114:1141-1149.
42. Quante M, SP Tu, H Tomita, T Gonda, SS Wang, S Takashi, GH Baik, W Shibata, B Diprete, et al. (2011). Bone marrowderived myofibroblasts contribute to the mesenchymal stem cell niche and promote tumor growth. Cancer Cell 19: 257-272.
43. Dunn GP, LJ Old and RD Schreiber. (2004). The immunobiology of cancer immunosurveillance and immunoediting. Immunity 21:137-148.
44. Yagi H, A Soto-Gutierrez, B Parekkadan, Y Kitagawa, RG Tompkins, N Kobayashi and ML Yarmush. (2010). Mesenchymal stem cells: mechanisms of immunomodulation and homing. Cell Transplant 19:667-679.
45. Svobodova E, M Krulova, A Zajicova, K Pokorna, J Prochazkova, P Trosan and V Holan. (2012). The role of mouse mesenchymal stem cells in differentiation of naive T-cells into anti-inflammatory regulatory T-cell or proinflammatory helper T-cell 17 population. Stem Cells Dev 21:901-910.
46. Han Z, Y Jing, S Zhang, Y Liu, Y Shi and L Wei. (2012). The role of immunosuppression of mesenchymal stem cells in tissue repair and tumor growth. Cell Biosci 2:8.
47. Patel SA, JR Meyer, SJ Greco, KE Corcoran, M Bryan and P Rameshwar. (2010). Mesenchymal stem cells protect breast cancer cells through regulatory T cells: Role of mesenchymal stem cell-derived TGF-beta. J Immunol 184:5885-5894.
48. Han Z, Z Tian, G Lv, L Zhang, G Jiang, K Sun, C Wang, X Bu, R Li, et al. (2011). Immunosuppressive effect of bone marrow-derived mesenchymal stem cells in inflammatory microenvironment favours the growth of B16 melanoma cells. J Cell Mol Med 15:2343-2352.
49. Tirode F, K Laud-Duval, A Prieur, B Delorme, P Charbord and O Delattre. (2007). Mesenchymal stem cell features of Ewing tumors. Cancer Cell 11:421-429.
50. Tsai KS, SH Yang, YP Lei, CC Tsai, HW Chen, CY Hsu, LL Chen, HW Wang, SA Miller, et al. (2011). Mesenchymal stem cells promote formation of colorectal tumors in mice. Gastroenterology 141:1046-1056.
51. Watanabe T, M Tada, H Nagai, S Sasaki and M Nakao. (1998). Helicobacter pylori infection induces gastric cancer in mongolian gerbils. Gastroenterology 115:642-648.
52. Lee JB, S Kuroda, H Shichinohe, J Ikeda, T Seki, K Hida, M Tada, K Sawada and Y Iwasaki. (2003). Migration and differentiation of nuclear fluorescence-labeled bone marrow stromal cells after transplantation into cerebral infarct and spinal cord injury in mice. Neuropathology 23:169-180.
53. Shi Y, XF Liu, Y Zhuang, JY Zhang, T Liu, Z Yin, C Wu, XH Mao, KR Jia, et al. (2010). Helicobacter pylori-induced Th17 responses modulate Th1 cell responses, benefit bacterial growth, and contribute to pathology in mice. J Immunol 184:5121-5129.
54. Bamford KB, XJ Fan, SE Crowe, JF Leary, WK Gourley, GK Luthra, EG Brooks, DY Graham, VE Reyes and PB Ernst. (1998). Lymphocytes in the human gastric mucosa during Helicobacter pylori have a T helper cell 1 phenotype. Gastroenterology 114:482-492.
55. Wu X, Z Zeng, B Chen, J Yu, L Xue, Y Hao, M Chen, JJ Sung and P Hu. (2010). Association between polymorphisms in interleukin-17A and interleukin-17F genes and risks of gastric cancer. Int J Cancer 127:86-92.
56. Flach CF, AK Ostberg, AT Nilsson, W Malefyt Rde and S Raghavan. (2011). Proinflammatory cytokine gene expression in the stomach correlates with vaccine-induced protection against Helicobacter pylori infection in mice: An important role for interleukin-17 during the effector phase. Infect Immun 79:879-886.
57. Szkaradkiewicz A, TM Karpinski, M Drews, M Borejsza- Wysocki, P Majewski and E Andrzejewska. (2010). Natural killer cell cytotoxicity and immunosuppressive cytokines (IL-10, TGF-beta1) in patients with gastric cancer. J Biomed Biotechnol 2010:901564.
58. Velin D, L Favre, E Bernasconi, D Bachmann, C Pythoud, E Saiji, H Bouzourene and P Michetti. (2009). Interleukin-17 is a critical mediator of vaccine-induced reduction of Helicobacter infection in the mouse model. Gastroenterology 136:2237-2246 e1.
59. Vignali DA, LW Collison and CJ Workman. (2008). How regulatory T cells work. Nat Rev Immunol 8:523-532.
60. Cheng HH, GY Tseng, HB Yang, HJ Wang, HJ Lin and WC Wang. (2012). Increased numbers of Foxp3-positive regulatory T cells in gastritis, peptic ulcer and gastric adenocarcinoma. World J Gastroenterol 18:34-43.